tiprankstipranks
Processa Pharmaceuticals, Inc. (PCSA)
NASDAQ:PCSA
US Market
PCSA
Processa Pharmaceuticals
RESEARCH TOOLSreports
Want to see PCSA full AI Analyst Report?

Processa Pharmaceuticals (PCSA) Income Statement

333 Followers

Processa Pharmaceuticals Income Statement

Last quarter (Q4 2025), Processa Pharmaceuticals's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q4, Processa Pharmaceuticals's net income was $-3.36M. See Processa Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ -1.20K$ 0.00$ 0.00$ 0.00$ 0.00
Operating Expenses
$ 13.99M$ 12.05M$ 11.46M$ 27.53M$ 12.13M
Depreciation and Amortization
$ 1.20K$ 782.00$ 222.00$ 788.50K$ 790.97K
EBITDA
$ -13.99M$ -12.05M$ -11.46M$ -19.47M$ -10.78M
Operating Income
$ -13.99M$ -12.05M$ -11.46M$ -27.53M$ -12.13M
Other Income/Expenses
$ 424.67K$ 201.09K$ 335.54K$ 101.20K$ 175.40K
Pretax Income
$ -13.56M$ -11.85M$ -11.12M$ -27.42M$ -11.96M
Net Income
$ -13.56M$ -11.85M$ -11.12M$ -27.42M$ -11.43M
Per Share Metrics
Basic EPS
$ -10.36$ -96.75$ -212.00$ -42.50$ -373.00
Diluted EPS
$ -10.36$ -96.75$ -212.00$ -42.50$ -373.00
Weighted Average Shares Outstanding
 1.31M 122.40K 52.46K 32.22K 30.64K
Weighted Average Shares Outstanding (Diluted)
 1.31M 122.40K 52.46K 32.22K 30.64K
Currency in USD

Processa Pharmaceuticals Earnings and Revenue History